CIK 0001641281
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Bolt Biotherapeutics, Inc.
Sign in to watch- Ticker
- BOLT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472804636
- Phone
- +1 650-665-9295
- Business address
- 900 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
- Former names
- Bolt Therapeutics, Inc.
- Open-market buys, last 90 days
- $319,000
- in 1 filing
- Open-market sales, last 90 days
- $128,281
- in 3 filings
Net +$190,719. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-12 | HEALY JAMES Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2023-06-12 | HEALY JAMES Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2022-06-10 | HEALY JAMES Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2022-03-24 | HEALY JAMES Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2021-02-09 | HEALY JAMES Director | Conversion | +1,104,209 | 1,104,209 | ||
| 2021-02-09 | HEALY JAMES Director | Conversion | +1,200,228 | 2,304,437 | ||
| 2021-02-09 | HEALY JAMES Director | Purchase | +450,000 | $20.00 | $9.0M | 2,754,437 |
| 2021-02-09 | HEALY JAMES Director | Conversion · Series C-1 Preferred Stock | −1,104,209 | 0 | ||
| 2021-02-09 | HEALY JAMES Director | Conversion · Series C-2 Preferred Stock | −1,200,228 | 0 |
Page 1 of 1 · 9 trades